FDA Grants QUOIN PHARMACEUTICALS Second Rare Pediatric Tag for QRX003

Quoin's lead asset QRX003 receives Rare Pediatric Disease Designation for Peeling Skin Syndrome, opening the door to a second Priority Review Voucher.